Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.71 CHF | +1.04% | +1.97% | +6.78% |
05-06 | NOVARTIS AG : UBS maintains a Buy rating | ZD |
05-02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.78% | 202B | |
+33.43% | 700B | |
+27.69% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.60% | 236B | |
-9.08% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis’ Oral Monotherapy for Rare Blood Disorder Secures EU Panel’s Nod